AIM Trials Company Profile
Background
Overview
AIM Trials is a clinical research organization based in Plano and Dallas, Texas, specializing in conducting Phase I-IV clinical trials across various therapeutic areas. Established in 2004, the company is dedicated to advancing medical knowledge and improving patient outcomes through innovative, patient-centered clinical research for both adults and children.
Mission and Vision
AIM Trials is committed to conducting research studies with dedication, quality, efficiency, and empathy. Their mission is to shatter the mental health stigma within the community and provide exceptional service and value to clients, partners, and patients.
Primary Area of Focus
The company focuses on a broad spectrum of conditions in mental and physical health, including depression, anxiety, Alzheimer's disease, bipolar disorder, pediatric autism, pediatric ADHD, pediatric migraine, and various other conditions.
Industry Significance
AIM Trials plays a vital role in conducting research across multiple therapeutic areas, evaluating the effectiveness and safety of new medications and treatments. Recognized among top clinical trial sites in Dallas and Plano, their studies span internal medicine, dermatology, cardiology, immunology, neurology, OB-GYN, psychiatry, oncology, pediatrics, and vaccines, serving diverse medical needs within the community.
Key Strategic Focus
Core Objectives
AIM Trials aims to advance health and wellness through innovative, patient-centered clinical research, focusing on delivering high-quality, ethical, and innovative clinical studies in various therapeutic areas for both pediatric and adult populations.
Specific Areas of Specialization
The company specializes in mental health trials, including depression, anxiety, bipolar disorder, and pediatric autism, as well as general health trials in areas such as internal medicine, dermatology, cardiology, immunology, neurology, OB-GYN, oncology, pediatrics, and vaccines.
Key Technologies Utilized
AIM Trials integrates modern technology for decentralized trials, combining remote participation with in-person or hybrid visits. This model supports broader accessibility and convenience for study participants.
Primary Markets or Conditions Targeted
The company targets a diverse range of conditions, including mental health disorders such as depression, anxiety, and bipolar disorder, as well as physical health conditions like asthma, COPD, dermatology issues, UTIs, and various others.
Financials and Funding
Specific details regarding AIM Trials' funding history, total funds raised, recent funding rounds, and notable investors are not publicly disclosed. The company has not publicly announced any recent funding rounds or disclosed the intended utilization of capital.
Pipeline Development
AIM Trials has successfully participated in over 50 clinical trials in both mental health and general health domains. Their patient database, which adheres to HIPAA regulations, now encompasses a substantial number of over 20,000 patients.
Technological Platform and Innovation
Proprietary Technologies
AIM Trials specializes in human factor and user experience (UX) research, integrating modern technology for decentralized trials that combine remote participation with in-person or hybrid visits.
Significant Scientific Methods
The company employs innovative approaches, including decentralized trials and hybrid models of in-person visits and telehealth, to enhance participant accessibility and trial efficiency.
Leadership Team
Sonia Prashar – Founder & CEO
Sonia has over 18 years of experience in clinical research, project management, and regulatory compliance in both drug and medical device trials. She leads a team of research professionals dedicated to delivering high-quality, ethical, and innovative clinical studies in various therapeutic areas for both pediatric and adult populations, with a focus on mental health.
Dr. Sejal Mehta, MD – Board Certified in Psychiatry
Dr. Mehta has over 25 years of clinical experience and has been serving as a Principal Investigator since 2010 in clinical trials with different indications. She is experienced in conducting trials in pediatric and adult populations and has been part of the community, largely involved in shattering the mental health stigma by partnering with different organizations.
Sameer Meharunkar – Chief Growth Officer
Sameer leads growth strategies at AIM Trials in Dallas-Fort Worth. With over 22 years of leadership experience in digital transformation and customer experience, he excels in healthcare and clinical trial management. At AIM Trials, he is responsible for strategic partnerships with sponsors, CROs, site networks, and technology vendors to accelerate clinical study growth.
Peter Thomas, PhD – Psychologist
Peter is a licensed psychologist in the State of Texas with over 20 years of clinical experience and over 5 years of experience in clinical research as a Sub-Investigator/Rater. He has experience conducting rating scales in both pediatric/adolescent and adult trials in different indications.
Crystal Salas – Research Nurse
Crystal is a board-certified Psychiatric Mental Health Nurse Practitioner and U.S. Army Veteran. With a nursing career spanning since 2010, she brings diverse experience from various healthcare settings, including ICU/Neonatal ICU, pediatric home health, neurology, inpatient treatment/chemical dependency, and utilization management.
Competitor Profile
Market Insights and Dynamics
The clinical research industry is experiencing significant growth, driven by the increasing demand for new treatments and therapies. Companies like AIM Trials play a crucial role in advancing medical knowledge and improving patient outcomes through innovative research.
Competitor Analysis
AIM Trials operates in a competitive landscape with several key players in the clinical research sector. Notable competitors include:
- Docbot: A healthcare technology company specializing in AI-driven solutions for medical imaging and diagnostics.
- Odin Vision: A company focused on AI-powered medical imaging analysis to enhance diagnostic accuracy.
- mediTective: A firm developing AI-based tools for medical decision support and patient management.
These competitors offer various technological innovations in the healthcare sector, contributing to the evolving landscape of clinical research and patient care.
Strategic Collaborations and Partnerships
AIM Trials collaborates with a diverse portfolio of sponsors and Contract Research Organizations (CROs) across the clinical research spectrum, including global pharmaceutical leaders, mid-size pharmaceutical companies, innovative biotech startups, major CROs, and emerging site networks.
Operational Insights
AIM Trials differentiates itself through its patient-centric approach, operational agility, and deep community connections, providing access to diverse patient populations. The company emphasizes personalized attention, responsive communication, and dedicated study teams to ensure the success of clinical trials.
Strategic Opportunities and Future Directions
AIM Trials is expanding into the promising field of psychedelic research, reflecting its commitment to staying at the forefront of medical research and contributing to the growing field of psychedelic-assisted therapies. The company aims to explore the therapeutic potential of psychedelic-assisted treatments within a highly regulated framework, continuing to lead with curiosity, care, and compliance.
Contact Information
AIM Trials operates clinical research sites in Plano and Dallas, Texas. For more information or to inquire about participation in clinical trials, visit their official website.
